R B Barkardottir

Mapping loss of heterozygosity at chromosome 13q: loss at 13q12-q13 is associated with breast tumour progression and poor prognosis.

J. Gudmundsson, B. Agnarsson, R. Barkardottir, 1998, European journal of cancer.

Nordic collaborative study of the BARD1 Cys557Ser allele in 3956 patients with cancer: enrichment in familial BRCA1/BRCA2 mutation-negative breast cancer but not in other malignancies

J. Kere, L. Aaltonen, P. Møller, 2006, Journal of Medical Genetics.

An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium.

A. Whittemore, J. Chang-Claude, B. Ponder, 1995, American journal of human genetics.

Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations.

J Isola, Å. Borg, O. Kallioniemi, 1997, Cancer research.